MATD3 Stock Overview
Provides health services in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Hospital Mater Dei S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$3.71 |
| 52 Week High | R$8.53 |
| 52 Week Low | R$3.63 |
| Beta | 0.48 |
| 1 Month Change | -13.92% |
| 3 Month Change | -20.22% |
| 1 Year Change | -53.97% |
| 3 Year Change | -71.89% |
| 5 Year Change | n/a |
| Change since IPO | -77.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| MATD3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -10.4% | -10.6% | -7.2% |
| 1Y | -54.0% | -31.7% | -11.5% |
Return vs Industry: MATD3 underperformed the BR Healthcare industry which returned -30% over the past year.
Return vs Market: MATD3 underperformed the BR Market which returned -9.2% over the past year.
Price Volatility
| MATD3 volatility | |
|---|---|
| MATD3 Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in BR Market | 9.2% |
| 10% least volatile stocks in BR Market | 2.7% |
Stable Share Price: MATD3 has not had significant price volatility in the past 3 months compared to the BR market.
Volatility Over Time: MATD3's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | n/a | Jose Henrique Salvador | www.materdei.com.br |
Hospital Mater Dei S.A. provides health services in Brazil. The company offers hospital, surgeries, oncology, medical appointments, exams, and other services. Hospital Mater Dei S.A. was founded in 1973 and is headquartered in Belo Horizonte, Brazil.
Hospital Mater Dei S.A. Fundamentals Summary
| MATD3 fundamental statistics | |
|---|---|
| Market cap | R$1.35b |
| Earnings (TTM) | -R$320.92m |
| Revenue (TTM) | R$2.28b |
0.6x
P/S Ratio-4.0x
P/E RatioIs MATD3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MATD3 income statement (TTM) | |
|---|---|
| Revenue | R$2.28b |
| Cost of Revenue | R$1.58b |
| Gross Profit | R$704.31m |
| Other Expenses | R$1.03b |
| Earnings | -R$320.92m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.93 |
| Gross Margin | 30.89% |
| Net Profit Margin | -14.07% |
| Debt/Equity Ratio | 97.6% |
How did MATD3 perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield-8%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 10:42 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hospital Mater Dei S.A. is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fred Mendes | BofA Global Research |
| Flavio Yoshida | BofA Global Research |
| Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |